The Monoclonal Antibodies (MAbs) Global Market Report 2021-31 by The Business Research Company describes and explains the global monoclonal antibodies market and covers 2016 to 2021, termed the historic period, and 2022 to 2026, termed the forecast period, along with further forecasts for the period 2026-2031. The report evaluates the market across each region and for the major economies within each region.
The Monoclonal Antibodies (MAbs) Global Market Report 2022 covers monoclonal antibodies market drivers, MAbs market trends, monoclonal antibodies market segments, MAbs market growth rate, monoclonal antibodies market major players, and MAbs market size.
View Complete Report:
https://www.thebusinessresearchcompany.com/report/monoclonal-antibodies-global-market-report
The monoclonal antibodies (MAbs) market report provides in-depth analysis of the impact of COVID-19 on the global monoclonal antibodies industry along with revised market numbers due to the effects of the coronavirus and the expected MAbs market growth numbers for 2022-2031.
The global monoclonal antibodies market size is expected to grow from $168.70 billion in 2021 to $188.18 billion in 2022 at a compound annual growth rate (CAGR) of 11.5%. The growth in the market is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The MAbs market share is expected to reach $292.22 billion in 2026 at a CAGR of 11.6%.
Request Report Sample Now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2554&type=smp
Monoclonal Antibodies (MAbs) Global Market Report 2022 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. The chapter also covers markets which have been positively affected by the pandemic.
TBRC’s report covers the monoclonal antibodies (MAbs) market segments-
1) By Source: Murine, Chimeric, Humanized, Human
2) By Application: Anti-Cancer, Immunological, Anti-Infective Monoclonal Antibodies, Neuropharmacological, Cardiovascular and Cerebrovascular, Others
3) By End-User: Hospitals, Private Clinics, Research Institutes
Table Of Contents
1. Executive Summary
2. Monoclonal Antibodies (MAbS) Market Characteristics
3. Monoclonal Antibodies (MAbS) Market Trends And Strategies
4. Impact Of COVID-19 On Monoclonal Antibodies (MAbS)
5. Monoclonal Antibodies (MAbS) Market Size And Growth
…
27. Monoclonal Antibodies (MAbS) Market Competitive Landscape And Company Profiles
28. Monoclonal Antibodies (MAbS) Pipeline Analysis
29. Key Mergers And Acquisitions In The Monoclonal Antibodies (MAbS) Market
30. Monoclonal Antibodies (MAbS) Market Future Outlook and Potential Analysis
About The Business Research Company:
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology. It has offices in the UK, the US and India and a network of trained researchers in 20+ countries globally.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Find us on
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany/
Blog: http://blog.tbrc.info/
